Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[p53 and colorectal cancer]

R Hamelin1, P Laurent-Puig

  • 1INSERM U434, Laboratoire de Génétique des Tumeurs, CEPH, Paris, France.

Pathologie-Biologie
|October 14, 1998
PubMed
Summary

Mutations in the p53 gene are common in colorectal cancer, affecting nearly half of tumors. While p53 gene mutations often predict a poor prognosis, immunohistochemistry results can conflict with mutation tests.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetic and transcriptomic analyses of early-onset colon cancer (EOCC): a <i>post hoc</i> analysis of 2973 patients from two adjuvant randomized trials.

ESMO gastrointestinal oncology·2026
Same author

Clinical impact of circulating tumor DNA to track minimal residual disease in colorectal cancer patients. Hopes and limitations.

ESMO gastrointestinal oncology·2026
Same author

Negative hyperselection of patients with stage III colon cancer receiving anti-EGFR-based adjuvant treatment.

ESMO open·2025
Same author

Effect of 5 years of CT-scan and CEA follow-up on survival endpoints in patients with colorectal cancer: the PRODIGE-13 FFCD phase III trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Predictive value of BRCA1/RAD51C methylation in HGSOC - An ancillary study of the PAOLA-1/ENGOT-ov25 phase 3 trial.

European journal of cancer (Oxford, England : 1990)·2025
Same author

Sarcomas developed in patients with Lynch Syndrome are enriched in pleomorphic soft-tissue sarcomas and are sensitive to immunotherapy.

European journal of cancer (Oxford, England : 1990)·2025

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Context:

  • p53 gene mutations are prevalent in colorectal cancer, identified in 49.5% of tumors across major studies.
  • Immunohistochemistry is often used to detect p53 alterations, as mutations can stabilize the protein.
  • Discrepancies exist between direct mutation testing and immunohistochemical detection of p53, with only 68% concordance.

Purpose:

  • To investigate the prevalence of p53 gene mutations in colorectal cancer.
  • To examine the concordance between p53 mutation analysis and immunohistochemical staining.
  • To clarify the prognostic significance of p53 alterations in colorectal cancer.

Summary:

  • p53 gene mutations were found in 380 of 768 (49.5%) colorectal tumors from large series.
  • Immunohistochemistry detects stabilized p53 protein, but concordance with mutation tests is only 68%.
  • While p53 mutation presence generally suggests a poor prognosis, conflicting data on staining significance exist.

Impact:

  • Highlights the frequent involvement of the p53 gene in colorectal tumorigenesis.
  • Underscores the need for careful interpretation of p53 testing methods in clinical practice.
  • Informs prognostic assessments and potential therapeutic strategies targeting p53 pathways in colorectal cancer.

Related Experiment Videos